Key result
Increased serum ADMA levels were significantly associated with the occurrence of coronary artery disease (P < 0.001) and showed a significant negative correlation with nitric oxide levels.
Why the study?
Are serum ADMA levels an independent predictor of CAD in patients with diabetes?
Case-Control (n=240)
Are serum ADMA levels an independent predictor of CAD in patients with diabetes?
Elevated serum ADMA levels are significantly associated with CAD and inversely correlated with NO levels, highlighting ADMA as a potential risk marker for cardiovascular events.
Answers are grounded in this paper and cite their sources.
ADMA may mark CAD risk; hypothesis-generating for independent prediction in diabetes and should not yet change practice.
Introduction. Asymmetric dimethylarginine (ADMA) is a nonselective nitric oxide (NO) synthase inhibitor associated with cardiovascular and metabolic disorders. ADMA plays an important role in the regulation of vascular tone by acting as an endogenous inhibitor of NO synthesis. Objectives. This study aimed to investigate ADMA with respect to diabetes and its clinical relevance as an independent predictor of CAD (Coronary Artery Disease). Methodology. The present case control study includes two hundred and forty patients selected randomly. Serum ADMA was analyzed by using enzyme immunoassay for the quantitative determination of endogenous ADMA, and serum nitric oxide was estimated by the method of Cortes. Results. Elevated NO level levels was a strong predictor and significantly (t: 9.86, P < 0.001) associated with occurrence of CAD. Increased ADMA level was found to be another strong predictor and associated significantly (t: 8.02, P < 0.001) with CAD. On intra group analysis, the relationship between ADMA and NO in diseased group, is significant negative correlation (r = -0.743). P (0.001) was found between ADMA and NO. Conclusion. ADMA level was found to be one of the strong predictors for CAD. ADMA is an emerging independent risk marker for future CVD (cardiovascular disease) events.
No takes yet. Share an insight, caveat, or question.
Jawalekar et al. (2013) conducted a case-control in Diabetes Mellitus and Coronary Artery Disease (n=240). Serum Asymmetric dimethylarginine (ADMA) concentration was evaluated on Occurrence of CAD (p=< 0.001). Increased serum ADMA levels were significantly associated with the occurrence of coronary artery disease (P < 0.001) and showed a significant negative correlation with nitric oxide levels.
Synapse has enriched 10 related papers. Consider them for comparative context: